HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Meng Selected Research

protosappanin A

10/2020Corrigendum to "Protosappanin A protects against experimental autoimmune myocarditis, and induces metabolically reprogrammed tolerogenic DCs" (Pharmacol. Res. 146 (2019) 104269).
1/2019Protosappanin A protects against experimental autoimmune myocarditis, and induces metabolically reprogrammed tolerogenic DCs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Meng Research Topics

Disease

39Neoplasms (Cancer)
02/2022 - 05/2005
23Fibrosis (Cirrhosis)
09/2021 - 07/2003
11Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 06/2008
6Infections
01/2022 - 01/2009
6Mental Disorders (Mental Disorder)
01/2022 - 01/2019
6Breast Neoplasms (Breast Cancer)
10/2021 - 11/2011
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 01/2010
6Ovarian Neoplasms (Ovarian Cancer)
08/2018 - 01/2014
5Lung Injury
01/2021 - 06/2004
5Insulin Resistance
01/2018 - 09/2004
4Inflammation (Inflammations)
01/2022 - 04/2014
4Neoplasm Metastasis (Metastasis)
01/2022 - 01/2021
4Obesity
08/2021 - 09/2004
4Stomach Neoplasms (Stomach Cancer)
01/2021 - 11/2011
3Sepsis (Septicemia)
01/2022 - 01/2019
3Wounds and Injuries (Trauma)
11/2021 - 01/2014
3Brain Neoplasms (Brain Tumor)
10/2021 - 10/2015
3Hepatocellular Carcinoma (Hepatoma)
06/2021 - 01/2019
3Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2020 - 02/2019
3Stroke (Strokes)
01/2020 - 01/2018
3Glioma (Gliomas)
01/2019 - 08/2015
3Emphysema
05/2015 - 06/2004
3Chronic Obstructive Pulmonary Disease (COPD)
09/2013 - 06/2004
2Malaria
02/2022 - 01/2022
2Acute Lung Injury
01/2022 - 06/2004
2Cicatrix (Scar)
01/2021 - 01/2020
2Myocarditis (Carditis)
10/2020 - 01/2019
2Hypertensive Retinopathy
10/2020 - 06/2017
2Prostatic Neoplasms (Prostate Cancer)
04/2020 - 01/2020
2Ischemic Stroke
01/2020 - 09/2011
2Meningioma (Meningiomas)
01/2020 - 10/2015

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
12/2021 - 07/2003
8Biomarkers (Surrogate Marker)IBA
02/2022 - 11/2013
8Angiotensin IIIBA
09/2021 - 01/2004
7Bleomycin (Blenoxane)FDA LinkGeneric
09/2021 - 06/2008
6Pharmaceutical PreparationsIBA
02/2022 - 01/2009
5Anti-Bacterial Agents (Antibiotics)IBA
02/2022 - 01/2009
5LipopolysaccharidesIBA
01/2022 - 09/2013
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 11/2013
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2015
5Type 1 Angiotensin ReceptorIBA
09/2021 - 07/2003
5CarbonIBA
02/2019 - 04/2015
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2010 - 07/2003
5PerindoprilFDA LinkGeneric
06/2008 - 07/2003
4EnzymesIBA
11/2022 - 04/2014
4Messenger RNA (mRNA)IBA
02/2022 - 07/2003
4Long Noncoding RNAIBA
03/2021 - 01/2018
4Therapeutic UsesIBA
02/2021 - 06/2004
4Coloring Agents (Dyes)IBA
02/2021 - 03/2006
4Blood Glucose (Blood Sugar)IBA
10/2020 - 09/2004
4angiotensin I (1-7)IBA
01/2018 - 04/2014
4AngiotensinsIBA
01/2018 - 07/2003
4AldosteroneIBA
10/2017 - 01/2007
4Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2008 - 07/2003
3Biological ProductsIBA
01/2022 - 12/2019
3InflammasomesIBA
11/2021 - 10/2017
3SmokeIBA
01/2021 - 06/2004
3UbiquitinIBA
08/2018 - 05/2015
3Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
08/2018 - 05/2015
3Doxorubicin (Adriamycin)FDA LinkGeneric
05/2018 - 04/2015
3Vitamin DFDA LinkGeneric
01/2018 - 01/2017
3hydroxide ionIBA
01/2018 - 01/2017
3Angiotensin-Converting Enzyme 2IBA
10/2017 - 04/2014
3Peptides (Polypeptides)IBA
08/2017 - 01/2012
3Eosine Yellowish-(YS) (Eosin)IBA
05/2015 - 03/2006
3Hematoxylin (Haematoxylon)IBA
05/2015 - 03/2006
3Hydroxyproline (4 Hydroxyproline)IBA
05/2013 - 06/2008
3NF-kappa B (NF-kB)IBA
06/2008 - 02/2005
3Losartan (Cozaar)FDA LinkGeneric
06/2008 - 07/2003
3Becaplermin (PDGF-BB)FDA Link
08/2005 - 07/2003
2artemisinin (artemisinine)IBA
02/2022 - 01/2022
2MicroRNAs (MicroRNA)IBA
02/2022 - 01/2022
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2022 - 01/2019
2Cadherins (E-Cadherin)IBA
12/2021 - 02/2012
2VimentinIBA
12/2021 - 02/2012
2Monoclonal AntibodiesIBA
10/2021 - 06/2021
2RNA (Ribonucleic Acid)IBA
10/2021 - 02/2017
2Temozolomide (Temodar)FDA LinkGeneric
10/2021 - 01/2019
2alamandineIBA
09/2021 - 01/2020
2CholesterolIBA
02/2021 - 10/2020
2LigandsIBA
02/2021 - 02/2016
2GlutaminaseIBA
01/2021 - 11/2019
2Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 01/2020
2Contrast MediaIBA
12/2020 - 08/2015
2protosappanin AIBA
10/2020 - 01/2019
2Triglycerides (Triacylglycerol)IBA
10/2020 - 04/2020
2Folic Acid (Vitamin M)FDA LinkGeneric
10/2020 - 01/2018
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2020 - 01/2018
2NitrogenIBA
02/2019 - 08/2015
2Glutamine (L-Glutamine)FDA Link
02/2019 - 01/2019

Therapy/Procedure

27Therapeutics
01/2022 - 06/2006
9Deep Brain Stimulation
01/2021 - 01/2019
4Drug Therapy (Chemotherapy)
01/2020 - 12/2015
3Transcranial Magnetic Stimulation
10/2020 - 02/2019
2Curettage
01/2021 - 01/2020
2Microbubbles
12/2020 - 01/2018
2Aftercare (After-Treatment)
10/2020 - 01/2020
2Transcranial Direct Current Stimulation
10/2020 - 02/2019
2Stents
09/2020 - 01/2020
2Castration
01/2020 - 11/2013